Last reviewed · How we verify

NCT05785962: ElectroVojta

Electromyographic Control of the Response in the Application of Vojta Therapy in People With Brain Injury.

Terminated NA Last updated 7 October 2025
What this trial tests

NA trial testing Vojta Therapy in Abdominal Muscles in 50 participants. Terminated before completion.

Timeline
1 September 2024
Primary endpoint
30 December 2024
25 June 2025

Quick facts

Lead sponsorUniversity of Salamanca
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment50
Start date1 September 2024
Primary completion30 December 2024
Estimated completion25 June 2025
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Salamanca

Who can join

Adults 18 to 80, any sex, with Abdominal Muscles. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A non-randomized clinical trial on a cohort of healthy subjects of legal age, both sexes, recruited from the university community and who will be randomly distributed into two groups (experimental and control). The objective will be to determine the feasibility of the standardized intervention protocol on the stabilizing muscles of the trunk (external oblique and internal oblique) before, during and after the application of Vojta Therapy, and to know the effects produced on the Musculature studied after performing the intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Vojta Therapy

Trials testing the same drug.

Other University of Salamanca trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05785962.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing